BioBusiness

Articles

Catalent will acquire Metrics Contract Services for $475 million to expand high-potent capabilities and oral development and manufacturing capacity.

Catalent to Acquire Metrics Contract Services for $475 Million

Amgen’s acquisition of Chemocentryx includes the autoimmune disease drug Tavneos (avacopan).

Amgen Will Acquire Chemocentryx in $4 Billion Deal

CRYOPDP is expanding its footprint to Spain with its acquisition of Polar Expres.

CRYOPDP Acquires Polar Expres

Boehringer Ingelheim has signed an option to acquire Trutino Biosciences.

Boehringer Ingelheim to Acquire Trutino Biosciences

GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9 billion.

GSK to Acquire Sierra Oncology for $1.9 Billion

Ymmunobio AG has signed a patent purchase agreement with LeukoCom GmbH to expand its development of cancer therapies.

Ymmunobio AG Signs Patent Purchase Agreement with LeukoCom GmbH

Pfizer plans to acquire ReViral and its respiratory syncytial virus therapeutic candidates to strengthen Pfizer’s capabilities in infectious disease research.

Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

Stanley Capital has announced the acquisition of MyMeds&Me by its portfolio company Drug Safety and Pharmacovigilance Services Solutions. 

Stanley Capital-Backed Portfolio Company DSS Acquires MyMeds&Me

Recipharm has strengthened its biologics manufacturing capabilities with the acquisition of both Vibalogics and Arranta Bio.

Recipharm Acquires Two Biologics CDMOs: Vibalogics and Arranta Bio

Sartorius Stedim Biotech has completed the acquisition of the chromatography equipment division of Novasep.

Mergers and Acquisitions